Connor, Clark & Lunn Investment Management (CC&L)’s MacroGenics MGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $826K | Sell |
682,277
-133,777
| -16% | -$162K | ﹤0.01% | 1107 |
|
|
2025
Q1 | $1.04M | Buy |
816,054
+71,152
| +10% | +$90.4K | ﹤0.01% | 934 |
|
|
2024
Q4 | $2.42M | Buy |
744,902
+82,988
| +13% | +$270K | 0.01% | 672 |
|
|
2024
Q3 | $2.18M | Buy |
661,914
+186,858
| +39% | +$615K | 0.01% | 647 |
|
|
2024
Q2 | $2.02M | Buy |
475,056
+56,774
| +14% | +$241K | 0.01% | 654 |
|
|
2024
Q1 | $6.16M | Buy |
418,282
+174,086
| +71% | +$2.56M | 0.03% | 385 |
|
|
2023
Q4 | $2.35M | Buy |
244,196
+104,945
| +75% | +$1.01M | 0.01% | 629 |
|
|
2023
Q3 | $649K | Buy |
+139,251
| New | +$649K | ﹤0.01% | 952 |
|
|
2022
Q4 | – | Sell |
-242,909
| Closed | -$840K | – | 1350 |
|
|
2022
Q3 | $840K | Buy |
242,909
+22,114
| +10% | +$76.5K | 0.01% | 694 |
|
|
2022
Q2 | $651K | Buy |
220,795
+175,342
| +386% | +$517K | ﹤0.01% | 717 |
|
|
2022
Q1 | $400K | Buy |
45,453
+5,657
| +14% | +$49.8K | ﹤0.01% | 821 |
|
|
2021
Q4 | $639K | Buy |
39,796
+3,528
| +10% | +$56.6K | ﹤0.01% | 758 |
|
|
2021
Q3 | $759K | Buy |
+36,268
| New | +$759K | ﹤0.01% | 690 |
|
|
2020
Q2 | – | Sell |
-65,619
| Closed | -$382K | – | 1124 |
|
|
2020
Q1 | $382K | Buy |
65,619
+35,994
| +121% | +$210K | ﹤0.01% | 757 |
|
|
2019
Q4 | $322K | Buy |
+29,625
| New | +$322K | ﹤0.01% | 750 |
|